71
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Isolation of new bibenzyl derivatives from Bulbophyllum auricomum and evaluation of their α-glucosidase inhibitory activity

, , , , &
Pages 437-447 | Received 26 Sep 2023, Accepted 15 Nov 2023, Published online: 29 Nov 2023
 

Abstract

Bulbophyllum auricomum Lindl., commonly referred to as the 'Royal Thazin' in Myanmar, holds the esteemed status of being the national flower of the country. In our research, we delved into the ethyl acetate extract derived from the pseudobulbs and roots of this plant. This extract exhibited significant inhibitory activity against the α-glucosidase enzyme, prompting a detailed investigation into its active compounds. Our study resulted in the isolation and characterization of several compounds, including a novel natural product named 2-(4-hydroxyphenyl) ethyl 3-(2-hydroxyphenyl) propanoate. Additionally, we identified two previously unreported inseparable isomeric bibenzyls, namely 7-hydroxybatatasin III and 8-hydroxybatatasin III. Furthermore, we isolated six known compounds, including batatasin III, lusianthridin, tristin, phochinenin G, phoyunnanin E, and phoyunnanin C. Significantly, our study unveiled that phochinenin G acts as a reversible noncompetitive inhibitor of the α-glucosidase enzyme. This compound displayed greater inhibitory activity than the standard drug acarbose.

GRAPHICAL ABSTRACT

Correction Statement

This article has been corrected with minor changes. These changes do not impact the academic content of the article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.